Market Cap (In USD)
8.77 Million
Revenue (In USD)
-
Net Income (In USD)
-1.27 Million
Avg. Volume
62.38 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.01-0.0225
- PE
- -
- EPS
- -
- Beta Value
- 0.909
- ISIN
- CA74141E1043
- CUSIP
- -
- CIK
- -
- Shares
- 541703000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Stephen Van Deventer
- Employee Count
- -
- Website
- https://www.preveceutical.com
- Ipo Date
- 2017-08-21
- Details
- PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
More Stocks
-
FIEMINDFiem Industries Limited
FIEMIND
-
BRNGFBuru Energy Limited
BRNGF
-
VIKASLIFEVikas Lifecare Limited
VIKASLIFE
-
ENET
-
RELXRELX PLC
RELX
-
9959
-
ITRG
-
NYKAA